Jeff Dieckhaus

Jeff Dieckhaus has a diverse work experience spanning various roles and industries. Jeff most recently served as the President of Meramec Group, Inc. from October 2019 onwards, and prior to that, they held the position of Vice President from June 2017 to October 2019.

Before joining Meramec Group, Inc., Jeff worked at Bausch + Lomb, where they were the Vice President of U.S. Surgical Marketing from September 2016 to June 2017. Prior to that, they held the role of Director of U.S. Surgical Marketing from May 2015 to September 2016.

Jeff also worked at TearLab Corporation as the Director of U.S. Marketing from November 2014 to May 2015, where they played a strategic role in developing the brand strategy, messaging, and positioning.

In addition, Jeff has experience in the healthcare industry, having worked as an Account Executive at Symantec from March 2014 to November 2014.

Jeff's early career includes significant roles at Alcon, A Novartis Division. Jeff served as the Director of Global Surgical Marketing, Cataract Franchise from October 2013 to March 2014, where they led and pioneered the growth of a surgical cataract diagnostic portfolio globally. Prior to that, they held several management positions within the company, including Manager of Global Surgical Marketing, Cataract Franchise and Group Manager of U.S. Anti-Inflammatory Marketing.

Before their time at Alcon, Jeff worked at ADP as a District Manager from May 1998 to February 2000.

Overall, Jeff Dieckhaus has extensive experience in sales, marketing, and leadership positions, with a focus on healthcare and medical technology industries.

Jeff Dieckhaus completed their Bachelor of Science in Business Administration from The University of Kansas, spanning from 1994 to 1999.